🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Dzifa Y. Duose

The University of Texas MD Anderson Cancer Center

ORCID: 0000-0002-6763-9736
Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.613Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251
Top 32%
0.613DataRank
Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Papers

Driven by 21 papers — median percentile 34. Top paper: “Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting”.

Development and Validation of a Gene Signature Classifier for Consensus Molecular Subtyping of Colorectal Carcinoma in a CLIA-Certified Setting

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-2403
N/A
1.5DataRank · unranked
34 citations

Rajyalakshmi Luthra, Yusha Liu, Dzifa Y. Duose, Wonyul Lee, Neelima G. Reddy +20 more

Impact of Philadelphia chromosome‐like alterations on efficacy and safety of blinatumomab in adults with relapsed/refractory acute lymphoblastic leukemia: A post hoc analysis from the phase 3 TOWER study

American Journal of Hematology(2021)10.1002/ajh.26281
N/A
0.952DataRank · unranked
32 citations

Keyur P. Patel, Nitin Jain, Dzifa Y. Duose, Rajyalakshmi Luthra, Nicholas J. Short +8 more

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

Frontiers in Oncology(2022)10.3389/fonc.2022.818679
N/A
0.830DataRank · unranked
20 citations

Marcus O. Butler, Russell K. Pachynski, Ryan J. Sullivan, Partow Kebriaei, Sarah Boross-Harmer +20 more

Cross-Site Concordance Evaluation of Tumor DNA and RNA Sequencing Platforms for the CIMAC-CIDC Network

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-3251
Top 32%
0.613DataRank
Top 32%15 citations

Jingxin Fu, Carrie Cibulskis, Aashna Jhaveri, Curtis Gumbs, Biswajit Das +41 more

Phase 1b Trial Evaluating Tolerability and Activity of Targeted Fibroblast Growth Factor Receptor Inhibition in Localized Upper Tract Urothelial Carcinoma

The Journal of Urology(2024)10.1097/ju.0000000000003928
N/A
0.411DataRank · unranked
8 citations

Mehrad Adibi, Amishi Y. Shah, Omar Alhalabi, Paul G. Corn, Charles C. Guo +8 more

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma

Neuro-Oncology(2025)10.1093/neuonc/noaf079
N/A
0.394DataRank · unranked
9 citations

Andrea G. Manzanera, Caroline Duault, Edgar Gonzalez‐Kozlova, Lenika Lopez, Stuart A. Grossman +50 more

Phase II basket trial of Dual Anti-CTLA-4 and anti-PD-1 blockade in Rare Tumors (DART) SWOG S1609: pancreatic neuroendocrine neoplasm (PNEN) cohort

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011760
N/A
0.245DataRank · unranked
4 citations

Jillian Fisher, Young Kwang Chae, Luisa M. Solis Soto, Anup Kasi, Bhavana Konda +27 more

Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin Lymphoma

Cancer Research Communications(2024)10.1158/2767-9764.crc-24-0252
N/A
0.208DataRank · unranked
3 citations

Hsin-Hui Huang, Opeyemi A. Jagede, Kevin Tuballes, Diane M. Del Valle, Geoffrey Kelly +19 more

Rapid detection of mutations in CSF-cfTNA with the Genexus Integrated Sequencer

Journal of Neuro-Oncology(2023)10.1007/s11060-023-04487-0
N/A
0DataRank · unranked
11 citations

Mauli Shah, Antonio Dono, Luis Nunez-Rubiano, Pavel S. Pichardo‐Rojas, Jay‐Jiguang Zhu +9 more

ANPEP/CD13 Expression as a Marker of Lymphovascular Invasion and Survival in Esophageal Adenocarcinoma

The Annals of Thoracic Surgery(2023)10.1016/j.athoracsur.2023.09.036
N/A
0DataRank · unranked
7 citations

Dipen M. Maru, Riham Katkhuda, Dzifa Y. Duose, Rajyalakshmi Luthra, Arlene M. Correa +4 more

Data from Bintrafusp Alfa, an Anti-PD-L1:TGFβ Trap Fusion Protein, in Patients with ctDNA-positive, Liver-limited Metastatic Colorectal Cancer

(2023)10.1158/2767-9764.c.6550830.v1
N/A
0DataRank · unranked
0 citations

Michael J. Overman, Michael Hon‐Wah Lam, Christine M. Parseghian, Benny Johnson, Arvind Dasari +17 more

Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-0251
N/A
0DataRank · unranked
42 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Data from Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial

(2024)10.1158/1078-0432.c.7181344.v1
Top 100%
0DataRank
Top 100%0 citations

Jiexin Zhang, Dzifa Y. Duose, Edgar Gonzalez‐Kozlova, Mary W. Redman, Hong Chen +42 more

Multiomics profiling and association with molecular and immune features in association with benefits from immunotherapy for patients with previously treated stage IV or recurrent squamous cell lung cancer from the phase III SWOG LungMAP S1400I trial.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.9046
N/A
0DataRank · unranked
0 citations

Dzifa Y. Duose, Jiexin Zhang, Mary W. Redman, Rossana Lazcano Segura, Mario L. Marques‐Piubelli +14 more

Resolving the spatial and cellular architecture of lung adenocarcinoma by multi-region single-cell sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.04.283739
N/A
0DataRank · unranked
18 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +36 more

Consensus molecular subtypes (CMS) as a marker for treatment and disease biology in metastatic colorectal cancer (CRC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.4089
N/A
0DataRank · unranked
2 citations

Preeti Kanikarla Marie, Amir Mehrvarz Sarshekeh, Van K. Morris, Dzifa Y. Duose, Baili Zhang +6 more

Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1285
N/A
0DataRank · unranked
134 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +35 more

Evaluation of the Oncomine Pan-Cancer Cell-Free Assay for Analyzing Circulating Tumor DNA in the Cerebrospinal Fluid in Patients with Central Nervous System Malignancies

Journal of Molecular Diagnostics(2021)10.1016/j.jmoldx.2020.10.013
N/A
0DataRank · unranked
32 citations

Takeshi Takayasu, Soheil Zorofchian Moghadamtousi, Octavio Arevalo, Melissa Chen, Chieh Lan +10 more

Evolutionary Action Score of TP53 Analysis in Pathologically High-Risk Human Papillomavirus-Negative Head and Neck Cancer From a Phase 2 Clinical Trial: NRG Oncology Radiation Therapy Oncology Group 0234

Advances in Radiation Oncology(2022)10.1016/j.adro.2022.100989
N/A
0DataRank · unranked
5 citations

Pedro A. Torres‐Saavedra, Natalie L. Silver, Paul M. Harari, Merrill S. Kies, D.I. Rosenthal +15 more

PI4KIIIβ is a therapeutic target in chromosome 1q–amplified lung adenocarcinoma

Science Translational Medicine(2020)10.1126/scitranslmed.aax3772
N/A
0DataRank · unranked
68 citations

Priyam Banerjee, Edward A. Pham, Florentine U. Rutaganira, Kaustabh Basu, Neus Bota‐Rabassedas +30 more

Phase II trial of neoadjuvant sitravatinib plus nivolumab in patients undergoing nephrectomy for locally advanced clear cell renal cell carcinoma

Nature Communications(2023)10.1038/s41467-023-38342-7
N/A
0DataRank · unranked
49 citations

Pavlos Msaouel, Cara Haymaker, Surena F. Matin, Matthew T. Campbell, Amado J. Zurita +17 more